» Articles » PMID: 35031927

Spectrum of MicroRNAs and Their Target Genes in Cancer: Intervention in Diagnosis and Therapy

Overview
Journal Mol Biol Rep
Specialty Molecular Biology
Date 2022 Jan 15
PMID 35031927
Authors
Affiliations
Soon will be listed here.
Abstract

Till date, several groups have studied the mechanism of microRNA (miRNA) biogenesis, processing, stability, silencing, and their dysregulation in cancer. The miRNA coding genes recurrently go through abnormal amplification, deletion, transcription, and epigenetic regulation in cancer. Some miRNAs function as tumor promoters while few others are tumor suppressors based on the transcriptional regulation of target genes. A review of miRNAs and their target genes in a wide range of cancers is attempted in this article, which may help in the development of new diagnostic tools and intervention therapies. The contribution of miRNAs for drug sensitivity or resistance in cancer therapy and opportunities of miRNAs in cancer prognosis or diagnosis and therapy is also presented in detail.

Citing Articles

Diagnostic value and clinical significance of serum miR-4534 combined with transvaginal color Doppler ultrasound in cervical cancer.

Shao X, Bai L, Liang J, Li M Discov Oncol. 2024; 15(1):403.

PMID: 39225917 PMC: 11372011. DOI: 10.1007/s12672-024-01282-9.


Insights into the Role of LncRNAs and miRNAs in Glioma Progression and Their Potential as Novel Therapeutic Targets.

Kciuk M, Yahya E, Mohamed M, Abdulsamad M, Allaq A, Gielecinska A Cancers (Basel). 2023; 15(13).

PMID: 37444408 PMC: 10340789. DOI: 10.3390/cancers15133298.


Plant extracellular vesicles: A novel bioactive nanoparticle for tumor therapy.

Tan Z, Li J, Luo H, Liu Y, Jin Y Front Pharmacol. 2022; 13:1006299.

PMID: 36249740 PMC: 9559701. DOI: 10.3389/fphar.2022.1006299.


Non-coding RNAs: the silent regulators of health and diseases.

Chakravorty N Mol Biol Rep. 2022; 49(7):6971-6973.

PMID: 35467178 PMC: 9036841. DOI: 10.1007/s11033-022-07464-4.

References
1.
Stark A, Lin M, Kheradpour P, Pedersen J, Parts L, Carlson J . Discovery of functional elements in 12 Drosophila genomes using evolutionary signatures. Nature. 2007; 450(7167):219-32. PMC: 2474711. DOI: 10.1038/nature06340. View

2.
Hata A, Kashima R . Dysregulation of microRNA biogenesis machinery in cancer. Crit Rev Biochem Mol Biol. 2015; 51(3):121-34. PMC: 5226641. DOI: 10.3109/10409238.2015.1117054. View

3.
Calin G, Sevignani C, Dumitru C, Hyslop T, Noch E, Yendamuri S . Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004; 101(9):2999-3004. PMC: 365734. DOI: 10.1073/pnas.0307323101. View

4.
Lu J, Getz G, Miska E, Alvarez-Saavedra E, Lamb J, Peck D . MicroRNA expression profiles classify human cancers. Nature. 2005; 435(7043):834-8. DOI: 10.1038/nature03702. View

5.
Thomson J, Newman M, Parker J, Morin-Kensicki E, Wright T, Hammond S . Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev. 2006; 20(16):2202-7. PMC: 1553203. DOI: 10.1101/gad.1444406. View